Table 3.
Demographics | MIS-C | Kawasaki disease |
---|---|---|
Age | ≤20 years, peak 6–11 years | <5 years |
Male: female ratio | 3:2 | 1.5:1 |
Ethnicity | High incidence in Japan, China, Taiwan, South Korea | High incidence in children of African and Hispanic heritage |
Clinical features | ||
Fever | 100% (+), ≥1 day | 100% (+), ≥5 days |
Conjunctival injection | 31%–83% | >90% |
Red, fissured lips | 30%–50% | >90% |
Strawberry tongue | 10% | >90% |
Cervical lymphadenopathy | 20%–70% | 20%–70% |
Skin rashes | 50%–70% | >90% |
Morphology | Macule, papules, urticarial-like, petechia, purpura | Macule, papules, urticarial-like |
BCG scar erythema | rare | 30%–40% |
Palmar/plantar edema and erythema | 26%–68% | 75% |
Shock | 40%–80% | 2%–7% |
Gastrointestinal symptom | 60%–100% | 20% |
Dyspnea | 19%–29% | Rare |
Neurological symptom | 13%–35% | 5%–39% |
Laboratory findings | ||
Lymphopenia | 37%–81% | rare |
Thrombocytopenia | 11%–31% | Uncommon |
Inflammatory markers | Increased ∼100% | Increased ∼100% |
Increased troponin | 33%–95% | rare |
Increased proBNP | 73%–95% | rare |
Increased ferritin | 54%–75% | rare |
Increased D-dimer | 91%–98% | rare |
Sterile pyuria | 50% | 50% |
Coronary artery dilatation | 14%–48% | 10%–30% |
Mortality rate | 1%–3% | <0.5% |
BCG, Bacillus Calmette-Guérin; proBNP, pro-brain natriuretic peptide.